Microcapsules comprising a fat-soluble active substance
Abstract
The invention relates to microcapsule comprising at least one fat-soluble active substance selected from provitamins, vitamins and esters thereof, monounsaturated fatty acids, polyunsaturated fatty acids (PUFA's), carotenoids and benzoquinones embedded in a matrix comprising a hydrocolloid and optionally one or more other matrix components, wherein the content of active substance(s) is from 30 to 60% of total weight of the microcapsule, and wherein the ratio between said fat-soluble active substance(s) and said hydrocolloid is at least 4:1, as well as a process for preparing such microcapsules. The microcapsules of the invention may be used for the preparation of tablets, food products and other products including an active substance.
Claims
exact text as granted — not AI-modified1 - 26 . (canceled)
27 . A microcapsule comprising at least one fat-soluble active substance selected from provitamins, vitamins and esters thereof, monounsaturated fatty acids, oils comprising polyunsaturated fatty acids (PUFA oils), carotenoids and benzoquinones embedded in a matrix comprising a hydrocolloid and optionally one or more other matrix components, wherein the content of active substance(s) is from 30 to 45% of total weight of the microcapsule, and wherein the ratio between said fat-soluble active substance(s) and said hydrocolloid is at least 6:1, and wherein the content of free surface fat is 2% or less.
28 . The microcapsule of claim 27 , wherein the content of active substance(s) is at least 35% of total weight of the microcapsule.
29 . The microcapsule of claim 27 , wherein the content of active substance(s) is at least 40% of total weight of the microcapsule.
30 . The microcapsule of claim 27 , wherein the ratio between said fat-soluble active substance(s) and said hydrocolloid is from 6:1 to 8:1.
31 . The microcapsule of claim 27 , where in the hydrocolloid is sodium or potassium caseinate.
32 . The microcapsule of claim 27 , wherein the matrix further contains antioxidants.
33 . The microcapsule of claim 27 , wherein the content of free surface fat in the microcapsule is less than 1% by weight based on the microcapsule.
34 . A process of preparing the microcapsule of claim 27 , which process comprises the steps of
providing a solution or dispersion of said hydrocolloid and said optionally other matrix components, adding to said solution or dispersion said at least one fat-soluble active substance, treating the mixture thus obtained to prepare a solution or dispersion of said at least one active substance in said matrix, finely dividing and drying the mixture thus obtained to prepare a mass of particles each containing said at least one active substance embedded in said matrix, wherein said at least one active substance and said hydrocolloid are used in a ratio of at least 6:1.
35 . The process of claim 34 , wherein said at least one active substance and said hydrocolloid are used in a ratio of from 6:1 to 8:1.
36 . A product comprising the microcapsule of claim 27 .
37 . A microcapsule comprising at least one fat-soluble active substance selected from the group consisting of monounsaturated fatty acids and oils comprising polyunsaturated fatty acids (PUFA oils) embedded in a matrix comprising a hydrocolloid selected from the group consisting of caseinates; further comprising a carbohydrate and optionally one or more other matrix components, wherein the content of active substance(s) is from 30 to 45% of total weight of the microcapsule, and wherein the ratio between said fat-soluble active substance(s) and said hydrocolloid is at least 6:1, and wherein the content of free surface fat is 2% or less.
38 . A microcapsule comprising at least one fat-soluble active substance selected from provitamins, vitamins and esters thereof, monounsaturated fatty acids, oils comprising polyunsaturated fatty acids (PUFA oils), carotenoids and benzoquinones embedded in a matrix comprising a hydrocolloid and optionally one or more other matrix components, wherein the content of active substance(s) is from 30 to 45% of total weight of the microcapsule, and wherein the ratio between said fat-soluble active substance(s) and said hydrocolloid is at least 6:1.Join the waitlist — get patent alerts
Track US2017112772A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.